AzTrials
AzTrials

Chronic PainNCT02296515

Intrathecal Pump Refill Undergoing Regular Intrathecal Pump Refill

An observational study of Chronic Pain, run by Dr med. Paolo Maino Viceprimario Anestesiologia at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Reservoir fill port identification by palpation versus ultrasound,a mono-centre prospective comparison study in patients undergoing regular intrathecal pump refill Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Chronic Pain
What is being tested?
Intrathecal pump refill:
Type of treatment
Surgery or procedure
How many people
33 participants
Where
1 siteSwitzerland
Study dates
Oct 2014to Nov 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: patients with an intrathecal pump for the treatment of chronic non-malignant pain or spasticity, undergoing regular refills of their intrathecal pumps at our Centro Terapia del Dolore at the Ospedale Italiano a Viganello(EOC, Switzerland).

Who may be able to join

  • 18 years or older at the time of enrollment;
  • The patients are treated for chronic non-malignant pain or spasticity with an intrathecal
  • programmable infusion pump and undergo regular refills of their pumps in our clinic.
  • Able to provide adequate given written, informed consent to participate in this study.

Who cannot join

  • patient refusal to participate or provide informed consent standard exclusions; pregnancy, lactation, treatment with other investigational products.
  • other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction,
  • cardiovascular disease).
  • infection at the puncture site -participation in another study.-

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Centro del Dolore, Neurocentro, Opedale Regionale di Lugano

    Lugano, Canton Ticino, 6900

Other trials in Switzerland

About this study

Official title: Intrathecal Pump Refill: Reservoir Fill Port Identification by Palpation Versus Ultrasound,a Mono-centre Prospective Comparison Study in Patients Undergoing Regular Intrathecal Pump Refill

Reservoir fill port identification by palpation versus ultrasound,a mono-centre prospective comparison study in patients undergoing regular intrathecal pump refill

Read the detailed description

Intrathecal drug therapy with implantable intrathecal pumps is being utilized increasingly for the treatment of chronic refractory pain and spasticity. However, performing the regular refill procedures of the pumps with the commonly performed "blind" technique caries the potential risk of medication injection into the subcutaneous tissue, which can lead to an overdose.

Objective: The primary purpose of this study is to assess the accuracy of the ultrasound-guided technique for the refill procedure compared to the blind technique in subjects undergoing regular refills of their intrathecal pumps for the treatment of chronic non-malignant pain or spasticity.

Study design: Mono-center prospective efficacy and reliability study comparing two approaches to enter the fill port. Study population: The investigators will include patients with an intrathecal pump for the treatment of chronic non-malignant pain or spasticity, undergoing regular refills of their intrathecal pumps at our Centro Terapia del Dolore at the Ospedale Italiano a Viganello(EOC, Switzerland). Intervention: Two different experienced clinicians will perform one time the blind technique and two times the ultrasound-guided technique on all patients.sample size calculations can be performed. The sample size i.e. n=25 patients in NSI-TD-001 Protocol v. 1.0 Final: August 4th, 2014 Confidential Page 31 of 40 total assessed 6 six times is therefore based on practical grounds related feasibility to duration of inclusion (i.e. one year). This would imply 50 paired assessments for both fill port accuracy assessment and intra-rater reliability. The investigators believe based on clinical experience that this number would suffice to detect a difference between methods. Likewise, although no formal power calculation are available for ICC based reliability assessment, as a rule of thumb 50 paired assessments are usually considered adequate to evaluate intra-rater liability.

Conditions
Chronic Pain
Being tested
Intrathecal pump refill:
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intrathecal pump refill:Procedure or surgery

    Two different experienced clinicians will perform one time the blind technique andTwo different experienced clinicians will perform one time the blind technique andtwo times the ultrasound-guided technique on all patients.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The primary endpoint will be the number of attempts to enter the reservoir fill port.

    The time to perform refill, and patient comfort associated with both procedures will be registered in order to assess user friendliness of both procedures.

    Measured: 1 YearThe sample size i.e. n=25 patients in total

Secondary outcomes (5)
  1. the number of skin puncturs

    Measured: 1 YearYearThe sample size i.e. n=25 patients in total

  2. reliability of the US guided procedure

    Measured: 1 YearYearThe sample size i.e. n=25 patients

  3. - time to perform refill (usability)

    Measured: 1 YearYearThe sample size i.e. n=25 patients

  4. patient discomfort

    Measured: 1 YearYearThe sample size i.e. n=25 patients

  5. - determine if BMI has an impact on the accuracy (the number of attempts) of the two techniques

    Measured: 1 YearYearThe sample size i.e. n=25 patients

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2014 (estimated)
  2. Study startOct 2014
  3. Primary completionNov 2017
  4. Study completionNov 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02296515
Sponsor's protocol ID
NSI_TD_001
Status last verified
Dec 2017
First submitted
5 Nov 2014
Last updated
3 Jan 2018
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Chronic Pain, run by Dr med. Paolo Maino Viceprimario Anestesiologia at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The primary endpoint will be the number of attempts to enter the reservoir fill port. (time frame: 1 YearThe sample size i.e. n=25 patients in total). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jan 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in